PuSH - Publikationsserver des Helmholtz Zentrums München: Concentration and activity of the soluble form of the interleukin-7 receptor α in type I diabetes identifies an interplay between hyperglycemia and immune function.

Informationen

Hinweise zu Qualitätskriterien von Zeitschriften

Open-Access-Richtlinie der Helmholtz-Gemeinschaft 2016

CC Licencences

Metriken für Publikationen

Navigation

Startseite

English

EVA: Veröffentlichen

Neuer EVA Antrag

Recherche

Erweiterte Suche

Durchblättern nach ...

... HMGU-Autoren/Konsortien

... Organisationsstruktur

... Zeitschriften

... Publikationstypen

... Forschungsdaten

... Arbeitsgruppen

... Erscheinungsjahr

Publikationen im Überblick

Statistik

HGF Fortschrittsbericht

OA Publikationen

Eintragen

Neue Publikation eintragen

Neue Publikation holen aus...

...EVA

Fehlende Publikation melden

Highlights

Suche

Hilfe & Kontakt

Ansprechpartner

Hilfe

Datenschutz

Helmholtz Open Science

Bibliometrische Indikatoren

SHERPA/RoMEO

DOAJ

Export:

Text

Endnote (RIS) BIB

BibTeX

Monti, P.* ; Brigatti, C.* ; Krasmann, M. ; Ziegler, A.-G. ; Bonifacio, E.*

Concentration and activity of the soluble form of the interleukin-7 receptor α in type I diabetes identifies an interplay between hyperglycemia and immune function.

Diabetes 62, 2500-2508 (2013)

Verlagsversion Volltext

DOI

PMC

	Closed

Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.

Abstract
Metriken
Zusatzinfos

Soluble IL-7 receptor alpha (sCD127) is implicated in the pathogenesis of autoimmune diseases. We show that serum sCD127 concentrations are increased at the onset of type 1 diabetes (n=390) as compared to concentrations in age-matched islet autoantibody negative first degree relatives of patients (n=392; P=0.00001). sCD127 Concentration in patients was influenced by islet autoantibody status (P=0.003) and genotype of the rs6897932 single nucleotide polymorphism within theIL-7RA gene (P=0.006). Release of sCD127 in vitro was strongly up-regulated by activation of T lymphocytes, and affected by exposure to cytokines. sCD127 bound IL-7 and was antagonistic to IL-7 signaling and IL-7 mediated T cell proliferation suggesting a regulatory feedback mechanism on T cell expansion. Remarkably, high glucose led to a glycated form of sCD127 that was ineffective as an IL-7 antagonist. The finding of glycated sCD127 in the circulation of patients at onset of type 1 diabetes suggested that physiological regulation of IL-7 mediated T cell survival and expansion by sCD127 may be compromised in type 1 diabetes. The findings indicate that genetic, immunologic and metabolic factors contribute to a dysregulation of the IL-7/IL-7 receptor pathway in type 1 diabetes, and identify a novel hyperglycemia mediated interference of immune regulatory networks.

Impact Factor

Scopus SNIP

Web of Science
Times Cited

Scopus
Cited By

Altmetric

7.895

2.093